MarketPeel
Insider Trading Intelligence
MS

Michael Shetzline

IRWD
CMO,SVP,HEAD-RES&DRUG · IRONWOOD PHARMACEUTICALS INC · CIK 0001808509
FILING MIX · LIFETIME43%/57%
BUYS
16
SELLS
21
TOTAL VALUE
$1.75M
COMPANIES
1
ACTIVE SINCE
Apr 2020
HOLDINGS NOW
658,037
AVG SELL PX
$8.88
TRADE KIND
SHOWING 37 / 37
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
21 backtested trades · 8 horizons · 7 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Michael Shetzline, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d21+57.14%+1.01%-0.38%+1.39%-2.67%
14d21+38.10%+3.36%-0.78%+4.14%+1.79%
30d21+52.38%-0.26%+1.31%-1.57%+0.16%
60d21+42.86%-0.14%+1.19%-1.33%+0.77%
90d21+47.62%-3.58%+2.29%-6.67%-2.92%
180d21(2 pending)+52.63%-7.46%+4.46%-11.92%+1.75%
1y21(2 pending)+36.84%+6.63%+9.81%-3.19%+4.35%
2y21(3 pending)+61.11%-23.17%+29.24%-52.41%-49.63%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IRWD · 658,037 shares · as of Mar 10, 2026
0164,509329,019493,528658,037202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 16 buys / 21 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
136,612658,037Mar 10, 2026Mar 12, 2026View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASE
SVP, CMO, Head-Res&Drug
17,012$3.66$62.3K521,425Feb 24, 2026Feb 25, 2026View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
SVP, CMO, Head-Res&Drug
15,570$3.81$59.3K538,437Feb 23, 2026Feb 25, 2026View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
133,333595,276Feb 10, 2025Feb 12, 2025View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
SVP, CMO, Head-Res&Drug
41,269$1.76$72.6K554,007Feb 10, 2025Feb 12, 2025View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
48,224461,943Jan 17, 2025Jan 22, 2025View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO,SVP,Head-Res&Drug
16,128$6.45$104.0K413,719May 20, 2024May 22, 2024View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO,SVP,Head-Res&Drug
34,9360Mar 8, 2024Mar 12, 2024View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASE
CMO,SVP,Head-Res&Drug
34,936429,847Mar 8, 2024Mar 12, 2024View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
27,21427,214Feb 12, 2024Feb 14, 2024View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO,SVP,Head-Res&Drug
38,618$15.24$588.5K340,484Feb 12, 2024Feb 14, 2024View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
54,427394,911Feb 12, 2024Feb 14, 2024View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
57,971379,102Jan 17, 2024Jan 19, 2024View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO,SVP,Head-Res&Drug
10,324$10.12$104.5K321,131May 22, 2023May 24, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
69,869331,455Mar 8, 2023Mar 10, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
34,93534,935Mar 8, 2023Mar 10, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO,SVP,Head-Res&Drug
7,438$11.31$84.1K264,002Feb 28, 2023Mar 1, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO,SVP,Head-Res&Drug
2,416$11.31$27.3K261,586Feb 28, 2023Mar 1, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO,SVP,Head-Res&Drug
7,146$11.41$81.5K273,762Feb 27, 2023Mar 1, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO,SVP,Head-Res&Drug
2,322$11.41$26.5K271,440Feb 27, 2023Mar 1, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
14,663280,908Jan 17, 2023Jan 19, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO,SVP,Head-Res&Drug
7,453$11.50$85.7K266,245May 23, 2022May 25, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO,SVP,Head-Res&Drug
3,130$11.50$36.0K273,698May 23, 2022May 25, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
81,448276,828Mar 2, 2022Mar 4, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO,SVP,Head-Res&Drug
3,804$10.77$41.0K199,744Feb 28, 2022Mar 2, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO,SVP,Head-Res&Drug
2,911$10.77$31.4K208,709Feb 28, 2022Mar 2, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO,SVP,Head-Res&Drug
1,367$10.77$14.7K211,620Feb 28, 2022Mar 2, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO,SVP,Head-Res&Drug
4,364$10.77$47.0K195,380Feb 28, 2022Mar 2, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO,SVP,Head-Res&Drug
5,161$10.77$55.6K203,548Feb 28, 2022Mar 2, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
29,326212,987Jan 19, 2022Jan 21, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO,SVP,Head-Res&Drug
13,776$11.58$159.5K183,661Nov 23, 2021Nov 24, 2021View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO, SVP & Head of Drug Devt.
2,077$12.25$25.4K197,437May 24, 2021May 26, 2021View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
38,655199,514Mar 26, 2021Mar 30, 2021View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO, SVP & Head of Drug Devt.
1,398$9.11$12.7K163,900Feb 26, 2021Mar 2, 2021View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
CMO, SVP & Head of Drug Devt.
3,041$9.11$27.7K160,859Feb 26, 2021Mar 2, 2021View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
58,252165,298Feb 22, 2021Feb 24, 2021View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
20,740107,046Apr 24, 2020Apr 28, 2020View →
Other insiders · IRWD
Loading peer insiders…
About this filer
CIK 0001808509
ROLE
CMO,SVP,Head-Res&Drug
PRIMARY
IRWD
COMPANIES
1
ACTIVE SINCE
Apr 2020
MARKETPEEL · /INSIDER/0001808509DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback